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Malaria accounts globally for more than 200 million new cases and 438,000 deaths per year. Since 
malaria is a disease of worldwide implications, combating it is one of the highest priority programs 
of the WHO. A worrisome increase in the number of fatal cases has been registered in recent years 
and it is principally due to the diffusion of multi-drug resistant strains of Plasmodium, making less 
effective the limited armamentarium of available drugs.1 Therefore, there is an urgent need of 
new antimalarial drugs with high efficacy against resistant strains and broad stage mode of action. 
To reach these challenging aims, the identification and selection of new lead compounds 
constitutes a crucial point. In this regard, nature remains an ever evolving resource. Recently, the 
antiplasmodial activity of marine secondary metabolites characterized by a quinone scaffold has 
been reported.2 In particular, it is worth to point out that a number of quinones have been shown 
to be effective antimalarials. The observed effects are most likely related to the most prominent 
chemical feature of these kind of molecules, that is their ability to undergo redox reaction i) 
shuttling electrons from reduced flavoproteins to acceptors such as hemoglobin-associated or free 
Fe(III)-protoporphyrin IX or ii) inhibiting the mitochondrial electron transport chain. In this context, 
recently, we were inspired by two marine metabolites Aplidinone A and B (figure 1) isolated from 
the Mediterranean ascidian Aplidium conicum,3 and we developed a series of synthetic analogues 
featuring the thiazinoquinone chemotype present in the natural metabolites with simplified side 
chains and different substituents. Manipulation of this chemical scaffold afforded additional 
analogues with improved pharmacological proprieties compared to the starting hits identified in 
the previous series (figure 1). 
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